億騰醫(yī)藥  Eddingpharm www.eddingpharm.com
億騰成立于2001年，作為中國領(lǐng)先的專業(yè)醫(yī)藥公司，我們長期以來一直致力于將全球優(yōu)質(zhì)的藥品帶入中國醫(yī)療市場，提供給病患更多的治療及康復(fù)機會，促進(jìn)中國臨床專家和全球領(lǐng)先醫(yī)學(xué)研究機構(gòu)的合作和交流，為中國臨床醫(yī)生提供學(xué)術(shù)支持。
公司自2001年成立以來，發(fā)展至2011年底，在國內(nèi)雇員已超過700名，主要從事藥品的經(jīng)銷和推廣、產(chǎn)品注冊以及臨床試驗的管理等業(yè)務(wù)。
公司于2012年3月在美國成立Eddingpharm (U.S.) Company,并在洛杉磯組建了具備研發(fā)背景的產(chǎn)品發(fā)展團(tuán)隊，主要從事與全球領(lǐng)先的研發(fā)機構(gòu)的協(xié)調(diào)和溝通，尋求將處于臨床前或臨床試驗階段的創(chuàng)新專利藥物引進(jìn)中國市場的機會。
公司聚焦于臨床營養(yǎng)、抗腫瘤治療、抗感染治療、呼吸系統(tǒng)疾病治療等領(lǐng)域的產(chǎn)品發(fā)展以及醫(yī)學(xué)推廣。
我們力爭通過和跨國醫(yī)藥公司、海外專業(yè)醫(yī)藥公司、全球領(lǐng)先研發(fā)機構(gòu)等合作，以專利授權(quán)引進(jìn)、成立合資公司、建立戰(zhàn)略聯(lián)盟、獨家經(jīng)銷等形式建立聚焦于上述四個主要治療領(lǐng)域的產(chǎn)品組合。
目前億騰已與多家跨國醫(yī)藥公司和海外專業(yè)醫(yī)藥公司建立起長期合作的關(guān)系，在上述四個治療領(lǐng)域建立了富有市場競爭優(yōu)勢的產(chǎn)品組合以及產(chǎn)品線；同時億騰還在積極發(fā)展與全球領(lǐng)先研發(fā)機構(gòu)合作,授權(quán)引進(jìn)創(chuàng)新藥物的中國市場權(quán)利。
經(jīng)過多年的努力，至2011年年底億騰的市場學(xué)術(shù)推廣人員發(fā)展超過600名，針對中國市場已形成一套高度整合與管理良好的市場營銷系統(tǒng)，醫(yī)學(xué)推廣覆蓋至全國大部分主要城市，同年12月底我們經(jīng)銷的產(chǎn)品或醫(yī)學(xué)推廣代表覆蓋至超過2900家醫(yī)院。

Eddingpharm was founded in 2001. As China’s leading pharmaceuticals marketing company, Eddingpharm has been committed to bring in high quality medicines from all over  the world to the Chinese market, to provide patients more treatment options and better opportunity of recovery.  We promote the cooperation and exchanges between Chinese clinical experts and the leading international medical research institutions. We provide academic support to Chinese clinical doctors.

Since its inception in 2001, the company has grown into an organization of more than 700 employees in China by the end of  2012. The company focuses on product sales and marketing, product registration,  and clinical trials management. 

In March, 2012, Eddingpharm established Eddingpharm (U.S.) Company in USA, and set up a business development team with strong research and development background. The team is engaged in coordination and communication with the world’s leading research and development institutions and biotech companies. It is actively seeking the opportunity to introduce innovative proprietary medicines in pre-clinical or clinical development phase into the Chinese market.

 
The company is engaged in the product development and sales and marketing in four core therapeutic areas: clinical nutrition, oncology, antibiotics and respiratory-system. 
 

We strive to create a portfolio of products focused on the above mentioned four major therapeutic areas, through strategic alliance, including exclusive distribution, product in-licensing, and joint-venture, with world’s leading pharmaceutical companies, overseas specialized pharmaceutical companies, and global leading research and development focused biotech companies. 
 

Eddingpharm has established long-term cooperative relationship with a number of multinational pharmaceutical companies and overseas specialty pharmaceutical companies, and has built up a competitive product portfolio and pipeline in the four major therapeutic areas. At the same time, Eddingpharm is actively developing cooperation with the leading global biotech companies and research and development institutions to gain the regional rights of innovative medicines and to introduce them to the China market.
 

Through years effort, Eddingpharm has assembled  a team of nearlysales and marketing professionals and established a highly integrated and well-managed sales network covering most of the major cities across the country. By December 2012, our products and our sales and marketing professionals have covered more than 3000 hospitals.